Thrombosis in vasculitis

Best Practice and Research: Clinical Rheumatology

Volumn 27, Issue 1, 2013, Pages 57-67

  Gaffo, Angelo L ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

ANCA vasculitis; Beh et's disease; Thrombo embolic disease; Thrombosis; Vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; ETANERCEPT; IMMUNOSUPPRESSIVE AGENT; LEVAMISOLE;

ANCA ASSOCIATED VASCULITIS; ANTICOAGULATION; AORTA ARCH SYNDROME; ARTICLE; BEHCET DISEASE; BUDD CHIARI SYNDROME; BUERGER DISEASE; CARDIOVASCULAR RISK; DEEP VEIN THROMBOSIS; FOLLOW UP; GIANT CELL ARTERITIS; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INTRACARDIAC THROMBOSIS; LOW DRUG DOSE; LUNG EMBOLISM; MORBIDITY; MORTALITY; MUCOCUTANEOUS LYMPH NODE SYNDROME; OCCLUSIVE CEREBROVASCULAR DISEASE; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUPERFICIAL THROMBOPHLEBITIS; THROMBOSIS; TREATMENT DURATION; VASCULAR DISEASE; VENOUS THROMBOEMBOLISM; WEGENER GRANULOMATOSIS;

EID: 84875202733     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2012.12.005     Document Type: Review

References (58)

1. C.N. Bagot, and R. Arya Virchow and his triad: a question of attribution British Journal of Haematology 143 2 2008 180 190 [Epub 2008/09/12]
2. D.J. Brotman, S.R. Deitcher, G.Y. Lip, and A.C. Matzdorff Virchow's triad revisited Southern Medical Journal 97 2 2004 213 214 [Epub 2004/02/26]
3. B. Furie, and B.C. Furie Mechanisms of thrombus formation The New England Journal of Medicine 359 9 2008 938 949 [Epub 2008/08/30]
4. Y. Allenbach, R. Seror, C. Pagnoux, L. Teixeira, P. Guilpain, and L. Guillevin High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients Annals of Rheumatic Diseases 68 4 2009 564 567 [Epub 2008/11/19]
5. Avina-Zubieta JA, Lacaille D, Sayre E, Kopec J, Choi H, editors. The risk of pulmonary embolism and deep vein thrombosis in giant cell arteritis: a population-based cohort study. Meeting of the American College of Rheumatology, October, 2012, Washington, D.C.
6. P.A. Merkel, G.H. Lo, J.T. Holbrook, A.K. Tibbs, N.B. Allen, and J.C. Davis Jr. Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study Annals of Internal Medicine 142 8 2005 620 626 [Epub 2005/04/20]
7. E. Seyahi, and S. Yurdakul Behcet's syndrome and thrombosis Mediterranean Journal of Hematology and Infectious Diseases 3 1 2011 e2011026 [Epub 2011/08/27]
8. P.M. Stassen, R.P. Derks, C.G. Kallenberg, and C.A. Stegeman Venous thromboembolism in ANCA-associated vasculitis-incidence and risk factors Rheumatology 47 4 2008 530 534 [Epub 2008/03/22]
9. S. Weidner, S. Hafezi-Rachti, and H.D. Rupprecht Thromboembolic events as a complication of antineutrophil cytoplasmic antibody-associated vasculitis Arthritis & Rheumatism 55 1 2006 146 149 [Epub 2006/02/08]
10. E. Kural-Seyahi, I. Fresko, N. Seyahi, Y. Ozyazgan, C. Mat, and V. Hamuryudan The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center Medicine 82 1 2003 60 76 [Epub 2003/01/25]
11. D. Eleftheriou, Y. Hong, N.J. Klein, and P.A. Brogan Thromboembolic disease in systemic vasculitis is associated with enhanced microparticle- mediated thrombin generation Journal of Thrombosis and Haemostasis 9 9 2011 1864 1867 [Epub 2011/07/08]
12. Y. Hong, D. Eleftheriou, A.A. Hussain, F.E. Price-Kuehne, C.O. Savage, and D. Jayne Anti-neutrophil cytoplasmic antibodies stimulate release of neutrophil microparticles Journal of American Society of Nephrology 23 1 2012 49 62 [Epub 2011/11/05]
13. Wegener's Granulomatosis Etanercept Trial Research Group Etanercept plus standard therapy for Wegener's granulomatosis The New England Journal of Medicine 352 4 2005 351 361 [Epub 2005/01/28]
14. J.K. Sebastian, B. Voetsch, J.H. Stone, Z. Romay-Penabad, G.H. Lo, and N.B. Allen The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event The Journal of Rheumatology 34 12 2007 2446 2450 [Epub 2007/10/09]
15. M.D. Morgan, J. Turnbull, U. Selamet, M. Kaur-Hayer, P. Nightingale, and C.J. Ferro Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a matched-pair cohort study Arthritis & Rheumatism 60 11 2009 3493 3500 [Epub 2009/10/31]
16. M. Faurschou, L. Mellemkjaer, I.J. Sorensen, B. Svalgaard Thomsen, L. Dreyer, and B. Baslund Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis Arthritis & Rheumatism 60 4 2009 1187 1192 [Epub 2009/04/01]
17. R. Suppiah, A. Judge, R. Batra, O. Flossmann, L. Harper, and P. Hoglund A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis Arthritis Care & Research (Hoboken) 63 4 2011 588 596 [Epub 2011/04/01]
18. F. Davatchi, F. Shahram, C. Chams-Davatchi, H. Shams, A. Nadji, and M. Akhlaghi Behcet's disease: from east to west Clinical Rheumatology 29 8 2010 823 833 [Epub 2010/04/01]
19. D. Saadoun, B. Wechsler, K. Desseaux, D. Le Thi Huong, Z. Amoura, and M. Resche-Rigon Mortality in Behcet's disease Arthritis & Rheumatism 62 9 2010 2806 2812 [Epub 2010/05/25]
20. Y. Koc, I. Gullu, G. Akpek, T. Akpolat, E. Kansu, and S. Kiraz Vascular involvement in Behcet's disease The Journal of Rheumatology 19 3 1992 402 410 [Epub 1992/03/01]
21. A. Gurler, A. Boyvat, and U. Tursen Clinical manifestations of Behcet's disease: an analysis of 2147 patients Yonsei Medical Journal 38 6 1997 423 427 [Epub 1998/03/24]
22. P.R. Ames, A. Steuer, A. Pap, and A.M. Denman Thrombosis in Behcet's disease: a retrospective survey from a single UK centre Rheumatology 40 6 2001 652 655 [Epub 2001/06/27]
23. R. Sarica-Kucukoglu, A. Akdag-Kose, I.M. Kayabal, K.D. Yazganoglu, R. Disci, and D. Erzengin Vascular involvement in Behcet's disease: a retrospective analysis of 2319 cases International Journal of Dermatology 45 8 2006 919 921 [Epub 2006/08/17]
24. N. Duzgun, A. Ates, O.T. Aydintug, O. Demir, and U. Olmez Characteristics of vascular involvement in Behcet's disease Scandinavian Journal of Rheumatology 35 1 2006 65 68 [Epub 2006/02/10]
25. H. Yazici, Y. Tuzun, H. Pazarli, S. Yurdakul, Y. Ozyazgan, and H. Ozdogan Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behcet's syndrome Annals of Rheumatic Diseases 43 6 1984 783 789 [Epub 1984/12/01]
26. K.T. Calamia, M. Schirmer, and M. Melikoglu Major vessel involvement in Behcet's disease: an update Current Opinion in Rheumatology 23 1 2011 24 31 [Epub 2010/12/03]
27. D. Saadoun, B. Wechsler, M. Resche-Rigon, S. Trad, D. Le Thi Huong, and A. Sbai Cerebral venous thrombosis in Behcet's disease Arthritis & Rheumatism 61 4 2009 518 526 [Epub 2009/04/01]
28. E. Seyahi, M. Melikoglu, C. Akman, V. Hamuryudan, H. Ozer, and G. Hatemi Pulmonary artery involvement and associated lung disease in Behcet disease: a series of 47 patients Medicine 91 1 2012 35 48 [Epub 2012/01/03]
29. S. Lakhanpal, K. Tani, J.T. Lie, K. Katoh, Y. Ishigatsubo, and T. Ohokubo Pathologic features of Behcet's syndrome: a review of Japanese autopsy registry data Human Pathology 16 8 1985 790 795 [Epub 1985/08/01]
30. N. Mogulkoc, M.I. Burgess, and P.W. Bishop Intracardiac thrombus in Behcet's disease: a systematic review Chest 118 2 2000 479 487 [Epub 2000/08/11]
31. N. Sengul, S. Demirer, M.A. Yerdel, G. Terzioglu, B. Akin, and A. Gurler Comparison of coagulation parameters for healthy subjects and Behcet disease patients with and without vascular involvement World Journal of Surgery 24 12 2000 1584 1588 [Epub 2001/02/24]
32. A. Gul, U. Ozbek, C. Ozturk, M. Inanc, M. Konice, and T. Ozcelik Coagulation factor V gene mutation increases the risk of venous thrombosis in Behcet's disease British Journal of Rheumatology 35 11 1996 1178 1180 [Epub 1996/11/01]
33. J.K. Ahn, Y.S. Lee, C.H. Jeon, E.M. Koh, and H.S. Cha Treatment of venous thrombosis associated with Behcet's disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation Clinical Rheumatology 27 2 2008 201 205 [Epub 2007/07/20]
34. Kahraman O, Celebi-Onder S, Kamali S, editors. Long-term course of deep vein thrombosis in patients with Behçet's disease. Meeting of the American College of Rheumatology, 2003, Orlando, FL.
35. A.C. Desbois, B. Wechsler, M. Resche-Rigon, J.C. Piette, T. Huong Dle, and Z. Amoura Immunosuppressants reduce venous thrombosis relapse in Behcet's disease Arthritis & Rheumatism 64 8 2012 2753 2760 [Epub 2012/02/23]
36. G. Hatemi, A. Silman, D. Bang, B. Bodaghi, A.M. Chamberlain, and A. Gul Management of Behcet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behcet disease Annals of Rheumatic Diseases 68 10 2009 1528 1534 [Epub 2008/04/19]
37. R. Manna, M. Latteri, G. Cristiano, L. Todaro, F. Scuderi, and G. Gasbarrini Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: a study of 40 cases British Journal of Rheumatology 37 2 1998 208 210 [Epub 1998/05/06]
38. B. Seriolo, M. Cutolo, A. Garnero, and S. Accardo Risk factors for thrombotic events in giant cell arteritis and polymyalgia rheumatica British Journal of Rheumatology 37 11 1998 1251 1253 [Epub 1998/12/16]
39. M.A. Gonzalez-Gay, T.R. Vazquez-Rodriguez, I. Gomez-Acebo, R. Pego-Reigosa, M.J. Lopez-Diaz, and M.C. Vazquez-Trinanes Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis Medicine 88 4 2009 227 235 [Epub 2009/07/14]
40. M.S. Lee, S.D. Smith, A. Galor, and G.S. Hoffman Antiplatelet and anticoagulant therapy in patients with giant cell arteritis Arthritis & Rheumatism 54 10 2006 3306 3309 [Epub 2006/09/30]
41. G. Nesher, Y. Berkun, M. Mates, M. Baras, A. Rubinow, and M. Sonnenblick Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis Arthritis & Rheumatism 50 4 2004 1332 1337 [Epub 2004/04/13]
42. J. Narvaez, B. Bernad, C. Gomez-Vaquero, C. Garcia-Gomez, D. Roig-Vilaseca, and X. Juanola Impact of antiplatelet therapy in the development of severe ischemic complications and in the outcome of patients with giant cell arteritis Clinical and Experimental Rheumatology 26 3 Suppl. 49 2008 S57 S62 [Epub 2008/10/24]
43. K. Maksimowicz-McKinnon, T.M. Clark, and G.S. Hoffman Takayasu arteritis and giant cell arteritis: a spectrum within the same disease? Medicine 88 4 2009 221 226 [Epub 2009/07/14]
44. A.W. de Souza, N.P. Machado, V.M. Pereira, A.E. Arraes, E.T. Reis Neto, and H.A. Mariz Antiplatelet therapy for the prevention of arterial ischemic events in takayasu arteritis Circulation Journal: Official Journal of the Japanese Circulation Society 74 6 2010 1236 1241 [Epub 2010/05/15]
45. G. Martin-Blondel, F. Koskas, P. Cacoub, and D. Sene Is thromboangiitis obliterans presentation influenced by cannabis addiction? Annals of Vascular Surgery 25 4 2011 469 473 [Epub 2011/05/10]
46. J.T. Lie Thromboangiitis obliterans (Buerger's disease) and smokeless tobacco Arthritis & Rheumatism 31 6 1988 812 813 [Epub 1988/06/01]
47. J. Eichhorn, D. Sima, C. Lindschau, A. Turowski, H. Schmidt, and W. Schneider Antiendothelial cell antibodies in thromboangiitis obliterans The American Journal of the Medical Sciences 315 1 1998 17 23 [Epub 1998/01/14]
48. F. Avcu, E. Akar, U. Demirkilic, E. Yilmaz, N. Akar, and A. Yalcin The role of prothrombotic mutations in patients with Buerger's disease Thrombosis Research 100 3 2000 143 147 [Epub 2000/12/08]
49. L. Maslowski, R. McBane, P. Alexewicz, and W.E. Wysokinski Antiphospholipid antibodies in thromboangiitis obliterans Vascular Medicine 7 4 2002 259 264 [Epub 2003/04/25]
50. M. Bradford, B. Rosenberg, J. Moreno, and G. Dumyati Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole Annals of Internal Medicine 152 11 2010 758 759 [Epub 2010/06/02]
51. K. Ullrich, R. Koval, E. Koval, S. Bapoje, and J.M. Hirsh Five consecutive cases of a cutaneous vasculopathy in users of levamisole-adulterated cocaine Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases 17 4 2011 193 196 [Epub 2011/05/28]
52. J. Graf, K. Lynch, C.L. Yeh, L. Tarter, N. Richman, and T. Nguyen Purpura, cutaneous necrosis, and antineutrophil cytoplasmic antibodies associated with levamisole-adulterated cocaine Arthritis & Rheumatism 63 12 2011 3998 4001 [Epub 2011/12/01]
53. T. Pearson, M. Bremmer, J. Cohen, and M. Driscoll Vasculopathy related to cocaine adulterated with levamisole: a review of the literature Dermatology Online Journal 18 7 2012 1 [Epub 2012/08/07]
54. B. Dasgupta, M.K. Almond, and A. Tanqueray Polyarteritis nodosa and the antiphospholipid syndrome British Journal of Rheumatology 36 11 1997 1210 1212 [Epub 1997/12/24]
55. B.K. Han, K. Inaganti, S. Fahmi, and A. Reimold Polyarteritis nodosa complicated by catastrophic antiphospholipid syndrome Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases 10 4 2004 210 213 [Epub 2006/10/18]
56. B. Zoller, X. Li, J. Sundquist, and K. Sundquist Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden Lancet 379 9812 2012 244 249 [Epub 2011/11/29]
57. H. Kato, and K. Takahashi Kawasaki's disease S.L. Bridges, G.V. Ball, Vasculitis 2008 Oxford University Press New York 373 389
58. H. Kato, S. Koike, and T. Yokoyama Kawasaki disease: effect of treatment on coronary artery involvement Pediatrics 63 2 1979 175 179 [Epub 1979/02/01]